4-Bromobenzo [b] thiophene CAS 5118-13-8 Tsafta > 97.0% (GC) Brexpiprazole Manufacturer Manufacturer

Takaitaccen Bayani:

Sunan Sinadarin: 4-Bromobenzo[b]thiophene

Saukewa: 5118-13-8

Tsafta:> 97.0% (GC)

Bayyanar: Hasken Rawaya Mai ƙarfi foda

Matsakaicin Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari 4-Bromobenzo [b] thiophene
Makamantu 4-Bromobenzothiophene;4-Bromo-Benzo[b]thiophene;4-Bromo-1-Benzothiophene
Lambar CAS 5118-13-8
Lambar CAT Saukewa: RF-PI1103
Matsayin Hannun jari A Stock, Capacity 30MT/Shekara
Tsarin kwayoyin halitta Saukewa: C8H5BrS
Nauyin Kwayoyin Halitta 213.09
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Hasken Rawaya Mai ƙarfi foda
Tsarkake / Hanyar Bincike > 97.0% (GC)
Infrared Spectrum Yayi daidai da Tsarin
NMR Yayi daidai da Tsarin
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Brexpiprazole (CAS: 913611-97-9)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

4-Bromobenzo [b] thiophene (CAS: 5118-13-8) ana amfani dashi azaman tsaka-tsaki mai amfani mai amfani, kuma ana fitar dashi galibi zuwa Indiya, Arewacin Amurka, Koriya, Jafananci, da Turai.4-Bromobenzo [b] thiophene matsakaici ne na Brexpiprazole (CAS: 913611-97-9).Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da Brexpiprazole a ranar 10 ga Yuli, 2015, don maganin schizophrenia, kuma a matsayin ƙarin magani don baƙin ciki.An ƙera Brexpiprazole don samar da ingantacciyar inganci da jurewa (misali, ƙarancin akathisia, rashin natsuwa da/ko rashin barci) akan kafaffen jiyya na haɗin gwiwa don babban rashin damuwa (MDD).Brexpiprazole, wanda ake sayar da shi a ƙarƙashin sunan alamar Rexulti da sauransu, maganin ciwon hauka ne.Brexpiprazole shine mai karɓar mai karɓa na D2 na ɓangare na agonist kuma an kwatanta shi a matsayin "serotonin-dopamine aiki modulator" (SDAM).Otsuka da Lundbeck ne suka haɓaka Brexpiprazole, kuma ana ɗaukarsa a matsayin magajin Otsuka na babban-sayar da atypical antipsychotic aripiprazole (Abilify).

Ku rubuta sakonku anan ku aiko mana